25 of the Best Pediatric Hematologist Oncologists Near Me in Washington, DC

Jeffrey Dome, MD, PhD, is senior vice president of the Cancer and Blood Disorders Center at Children’s National Hospital in Washington, D.C. He is professor of pediatrics at the George Washington University School of Medicine and Health Sciences and the Thomas Willson and Lenore Williams McKnew professor of pediatric oncology. Dr. Dome received his medical degree from the University of Pennsylvania School of Medicine and PhD degree in medicine from Erasmus University in Rotterdam. He completed a residency in pediatrics at Yale-New Haven Hospital and completed a fellowship in pediatric hematology/oncology at Johns Hopkins Hospital. After fellowship, Dr. Dome was a faculty member at St. Jude Children’s Research Hospital before joining Children’s National in 2006. Dr. Dome is an internationally recognized expert on pediatric solid tumors, with an emphasis on kidney tumors and sarcomas. He chaired the Children’s Oncology Group (COG) Renal Tumor Committee for more than a decade. He is presently on the Scientific Council of the COG, the editorial board of Pediatric Blood and Cancer, and is past chair of the American Board of Pediatrics Subboard of Hematology/Oncology. Dr. Dome serves on numerous medical advisory boards for cancer foundations and currently is the North American Continental President of the International Society of Pediatric Oncology (SIOP). He has authored more than 200 articles, books, letters and chapters on pediatric cancer. Dr. Dome is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Rhabdoid Tumor, Denys-Drash Syndrome (DDS), Adult Soft Tissue Sarcoma, Nephrectomy, and Bone Marrow Aspiration. Dr. Dome is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 1998.

Holly Meany, MD, is a pediatric oncologist and director of the Solid Tumor Program at Children’s National Hospital. She also serves as an associate professor of pediatrics at George Washington University. Dr. Meany is dedicated to finding better treatments for children with cancer through research and clinical care. Her work focuses on developing new therapies for pediatric solid tumors. She designs and leads early-phase clinical trials to test promising treatments and understand how they work in children. Dr. Meany has played a key role in several national studies, including large trials for neuroblastoma, a type of childhood cancer. She recently led an international study for children with newly diagnosed non-high-risk neuroblastoma and is currently helping to develop the next high-risk neuroblastoma trial, both through the Children’s Oncology Group. Dr. Meany is also exploring innovative approaches like immunotherapy—using the body’s own immune system to fight cancer. She has led international studies using specialized T cells to treat patients with relapsed solid tumors and is now working on combining these novel T cells with CAR T-cell therapy for children with relapsed cancers. In addition to her research, Dr. Meany is passionate about training the next generation of pediatric cancer specialists. As director of the Pediatric Hematology-Oncology Fellowship Program at Children’s National, she mentors and supports future leaders in the field. Dr. Meany is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Neuroblastoma, Hereditary Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Osteosarcoma, and Mastoidectomy. Dr. Meany is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2006 and Pediatrics: American Board Of Pediatrics, 2003.

Elizabeth Yang is a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. She has been practicing medicine for over 39 years. Dr. Yang is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia. Dr. Yang is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 1994 and Pediatrics: American Board Of Pediatrics, 1990.

Luca Szalontay is a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. She has been practicing medicine for over 17 years. Dr. Szalontay is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Glioma, Diffuse Midline Glioma H3 K27M-Mutant, Medulloblastoma, and Brain Stem Cancer. Dr. Szalontay is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2021 and Pediatrics: American Board Of Pediatrics, 2015.

Urania Dagalakis, MD, MHSc, specializes in pediatric oncology and hematology. She completed her clinical training at Johns Hopkins University and conducted her research work within the National Cancer Institute of the National Institutes of Health. Due to her research background she specializes in caring for children with rare tumors and hereditary cancer syndromes. Dr. Dagalakis is the director of the Cancer Genetics Clinic at Children’s National Hospital. She is also an assistant professor of pediatrics at The George Washington University School of Medicine and Health Sciences and a physician in the Center for Cancer and Blood Disorders. She is committed to empowering families with knowledge, supporting survivorship and leading innovations in personalized cancer care. Her work bridges compassionate patient care with clinical research focused on improving outcomes for children with genetic cancer predispositions. Dr. Dagalakis is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Hemoglobin SC Disease and Immune Thrombocytopenic Purpura (ITP). Dr. Dagalakis is board certified in Pediatrics: American Board Of Pediatrics, 2023.

Hyojeong Han is a Transfusion Medicine specialist and a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. She has been practicing medicine for over 13 years. Dr. Han is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Anemia, and Hemolytic Anemia. Dr. Han is board certified in American Board Of Pathology, 2021, American Board Of Pediatrics, 2021, and American Board Of Pediatrics, 2016.

Nita L. Seibel, MD, is a board-certified pediatrician and pediatric hematologist-oncologist. After graduating from the Ohio State University College of Medicine in 1988, she completed her internship and residency at the Ohio State University Children’s Hospital in 1984. Dr. Seibel completed a fellowship in pediatric hematology-oncology at the Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health in 1987. She joined the faculty of Children's National Hospital in 1988 and is a professor of pediatrics at the George Washington University School of Medicine & Health Sciences. While at Children's National, Dr. Seibel has served for over 15 years on the Institutional Review Board, as Director of the Hematology/Oncology Training Program for nine years and as Principal Investigator for Children's Oncology Group. Dr. Seibel has chaired numerous studies for the Children’s Oncology Group including chairing the Phase I Data Safety Monitoring Committee and served as vice-chair for Phase I agents. Dr. Seibel was also a member of the National Wilms Tumor Study and later the COG Renal Tumor Committee. Dr. Seibel's areas of special interest are: Wilms tumor, bone tumors, ALL, and adolescent and young adult oncology as well as late effects. She also has a special interest in Acute Lymphoblastic Leukemia in adolescents and young adults and anti-fungal agents. Dr. Seibel is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Adult Soft Tissue Sarcoma, and Infantile Neutropenia. Dr. Seibel is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 1987 and Pediatrics: American Board Of Pediatrics, 1986.

Ashley Lanzel, MD, MA, trained in pediatrics at Johns Hopkins Hospital, pediatric hematology-oncology at Emory/Children’s Healthcare of Atlanta, and hospice and palliative medicine at the National Institutes of Health. While at Emory University, she obtained a Master of Arts in bioethics. Her research focus is in decision-making, communication, palliative oncology and pediatric palliative ethics. She enjoys being a clinical educator. When she is not at work, she is having fun with her kids. Her clinical expertise encompasses GM1 Gangliosidosis, Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome), and Mucopolysaccharidoses (MPS). Dr. Lanzel is board certified in American Board Of Pediatrics, 2022, Pediatric Hematology-Oncology: American Board Of Pediatrics, 2019, and Pediatrics: American Board Of Pediatrics, 2015.

Hannah Kinoshita, MD, is an oncologist in the Division of Oncology in the Center for Cancer and Blood Disorders. Her research interests include cellular immunotherapy for high-risk hematologic malignancies. Her clinical expertise encompasses Multisystem Inflammatory Syndrome in Children (MIS-C), Acute Lymphoblastic Leukemia (ALL), Leukemia, Medulloblastoma, and Bone Marrow Transplant. Dr. Kinoshita is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2023 and American Board Of Pediatrics, 2018.

Jennifer Levine is a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. She has been practicing medicine for over 27 years. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Malignant Peripheral Nerve Sheath Tumor, Febrile Neutropenia, and Medulloblastoma. Dr. Levine is board certified in American Board Of Pediatrics, 2006 and American Board Of Pediatrics, 2003.

Susan Whiteway is a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. She has been practicing medicine for over 20 years. Her clinical expertise encompasses Chromosome 7p Deletion, Ewing Sarcoma, RASopathies, and Osteosarcoma. Dr. Whiteway is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2013 and Pediatrics: American Board Of Pediatrics, 2009.

Lea Mayer is a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. She has been practicing medicine for over 16 years. Her clinical expertise encompasses Marshall-Smith Syndrome, Cantu Syndrome, Hemi 3 Syndrome, and Megalencephaly-Capillary Malformation Syndrome. Dr. Mayer is board certified in Oncology Nursing Certification Corporation, 2015 and Primary Care Certified Pediatric Nurse Practitioner (CPNP-PC): Pediatric Nursing Certification Board, 2010.

Thomas Newton is a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. He has been practicing medicine for over 30 years. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Sickle Cell Disease, Febrile Neutropenia, and Hemolysis. Dr. Newton is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2009 and Pediatrics: American Board Of Pediatrics, 1999.

Hari Sankaran is a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. He has been practicing medicine for over 19 years. His clinical expertise encompasses Classical Hodgkin Lymphoma. Dr. Sankaran is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2017 and Pediatrics: American Board Of Pediatrics, 2012.

Denise Casey is a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. She has been practicing medicine for over 24 years. Dr. Casey is board certified in American Board Of Pediatrics, 2011 and Pediatrics: American Board Of Pediatrics, 2005.

Michael Terao, MD, MEd, is a bone marrow transplant hospitalist at Children’s National Hospital and also works as the assistant dean for student learning at the Georgetown University School of Medicine. He received his Bachelor of Arts in English at Allegheny College in Meadville, PA. Dr. Terao graduated from Eastern Virginia Medical School and completed a pediatric residency at UCSF Benioff Children’s Hospital Oakland. After completing residency, he served as pediatric chief resident at the Morehouse School of Medicine Pediatric Residency. He then completed pediatric hematology/oncology fellowship at St. Jude Children's Research Hospital. Dr. Terao also received his Master of Education in the health professions from the Johns Hopkins University. As a cancer survivor himself, Dr. Terao strongly believes in the importance of delivering clinical care that is of the highest quality possible while also being compassionate and empathetic. Dr. Terao has published multiple peer-reviewed manuscripts with his research interests focusing on how to best support learners in medical education who struggle with multiple choice question examinations. Dr. Terao is board certified in general pediatrics and pediatric hematology/oncology. Dr. Terao is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2021 and Pediatrics: American Board Of Pediatrics, 2016.

Brianna Nolan is a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. She has been practicing medicine for over 3 years. Dr. Nolan is board certified in Pediatric Nursing Certification Board, 2024.

Katie McHugh, CPNP-AC, is a pediatric nurse practitioner with the Leukemia and Lymphoma and Histiocytosis Programs within the Children’s National Cancer and Blood Disorders Center. She received her undergraduate degree from the University of North Carolina in 2007, holds a master’s degree from the University of Maryland, and earned her nurse practitioner degree from the University of Virginia. She has worked in pediatric oncology for over a decade and a half. She is an active board member of the Washington, D.C., chapter of the Association of Pediatric Hematology/Oncology Nurses. Outside of work, she enjoys running, gardening and cheering on the Tar Heels during basketball season. Dr. Mchugh is board certified in Acute Care Certified Pediatric Nurse Practitioner (CPNP-AC): Pediatric Nursing Certification Board, 2023.

Shelby Smith is a Pediatrics specialist and a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. She has been practicing medicine for over 13 years. Dr. Smith is board certified in Pediatric Nursing Certification Board, 2016.